Navigation Links
Pergamum to Provide Effective Development of Innovative Dermatology and Wound Healing Companies
Date:9/10/2009

rsjostiftelsen (The Foundation for Baltic and East European Studies) and Midroc New Technology.

Karolinska Development's CEO, Conny Bogentoft, said, "We are extremely pleased with this new initiative. By consolidating all of our interests in the dermatology and wound healing field in this way we have created an extremely resource-efficient business model. It should provide both more effective project development and greater efficiency when seeking exit opportunities."

About Karolinska Development:

Managing one of the largest portfolios of life science research companies in Europe, Karolinska Development

AB is a new type of company focused on filling the innovation gap within the pharmaceutical industry. Using a unique, highly cost-effective model Karolinska Development commercializes internationally renowned life science innovations, helping to deliver the medical products of the future.

    For more information please contact:

    Magnus Precht, CEO, Pergamum AB
    European mobile phone: +46-73-515-7450
    US cell phone:         +1-817-312-7277
    magnus.precht@pergamum.com
   http://www.pergamum.com

    Conny Bogentoft, CEO, Karolinska Development AB
    Cell phone: +46-70-668-61-43
    info@karolinskadevelopment.com
   http://www.karolinskadevelopment.com

'/>"/>
SOURCE Karolinska Development AB
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. PharmaNet Development Group Provides Financial Update and Announces Geographic Expansion
2. Hyland Software Provides Grant Assistance to Kick-Start Technology Projects
3. PDL BioPharma Provides Third Quarter 2009 Revenue Guidance of Approximately $71 Million
4. ValGenesis, Inc., the Leading Provider of Validation Lifecycle Management Solutions to Regulated Life Science Companies, Today Announced Support for EMC Documentum v.6.5
5. ChemBridge Corporation and Collaborative Drug Discovery Announce Strategic Collaboration to Provide Diverse Chemical Libraries Together With Researchers Own Private Data
6. Ambry Genetics Announces Certified Service Provider Status for Agilent Microarrays
7. Leading European Contract Research Organization Selects OmniComm to Provide eClinical Solutions for Important Phase III Study
8. Wyeth Provides Regulatory Update on Prevnar 13* in the United States
9. Sigma-Aldrich Acquires ChemNavigator, Inc., to Provide Researchers With Industry-Leading Chemical Compound Selection and Procurement Services
10. ThermoGenesis Provides Update on Fiscal 2009 Results
11. GeoVax Labs, Inc. Provides Clinical Studies Update

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...ire/ -- Dr. Mate Hidvegi, inventor of Avemar ferme...se issued on November 17 by Biropharma Kft, discre...self-serving statements about its U.S. competitor ...om his office in Budapest, Hungary: ,, "The Bi...ply to AveULTRA, www.aveultra.com , is misleadi...
(Date:11/19/2009)...rstCall/ -- NeoStem, Inc. (NYSE Amex: NBS ), anno...to its shareholders, discussing the Company,s acqu...uticals Holdings, Inc. (CHBP), an integrated bio-p...ic of China. The merger gives NeoStem a controllin...td., CHBP,s primary operating subsidiary and a pro...
(Date:11/19/2009)...ss., Nov. 19 Arlington Medical Res...leading driver of antibiotic selection in nosocomi...against gram-positive and gram-negative pathogens....socomial pneumonia, surveyed European physicians r...vide appropriate coverage against common pathogens...
(Date:11/19/2009)... Aegera Therapeutics Inc. announced today the dosi...tudy of AEG35156, a targeted antisense therapeutic...dications. ,, The study, entitled "An Open-Labe...or of Apoptosis (XIAP) Antisense AEG35156 Given in...cin in AML Following Failure of a Single Standard ...
Breaking Biology Technology:American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2
..., Inc.,(CTI) (Nasdaq and MTA: CTIC) today announce...K for the year ended December 31, 2007 has now bee...eview on CTI,s Web site at, http://www.CellTherape...ssion,s Web site at http://www.sec.gov ., As req... CTI also,announced that its independent auditor,s...
...h 28 Eisai Co.,Ltd. and its U.S. subsidiary Eisai...the United States District Court for the District ...ect to Eisai,s motion for a,preliminary injunction...harmaceuticals and its division Gate Pharmaceutica...eneric name: donepezil hydrochloride,tablets)., A...
...nternational, Inc. (Amex: BUF ) today announced i...David T. DiGiacinto as President and Chief,Operati...take over the,day-to-day operations of the Company...n a transition in which he will become Chief Execu..., 2009. William H. Burns, Jr. will,continue to ser...
Other Biology Technology:Eisai is Granted Favorable Preliminary Injunction Ruling in Aricept(R) Patent Infringement Lawsuit Against Teva Pharmaceuticals 2Eisai is Granted Favorable Preliminary Injunction Ruling in Aricept(R) Patent Infringement Lawsuit Against Teva Pharmaceuticals 3MINRAD International, Inc. Announces Appointment of David T. DiGiacinto as President and Chief Operating Officer 2MINRAD International, Inc. Announces Appointment of David T. DiGiacinto as President and Chief Operating Officer 3MINRAD International, Inc. Announces Appointment of David T. DiGiacinto as President and Chief Operating Officer 4
(Date:11/20/2009)...: Toxins in coal-tar-based sealcoats in parking lo...according to a USGS study. PAHs or polycyclic ar...oil, coal and tar deposits, and can have toxic eff...nd in house dust; however, the specific sources of...found that dust from indoor areas near parking lot...
(Date:11/20/2009)...available in German . , In the current onli... , Dr. Stefanie Eyerich and Dr. Kilian Eyerich tog...London and Istituto Dermopatico dell,Immacolata in...represents a milestone on the way to developing ne... such as psoriasis and allergic reactions and pote...
(Date:11/20/2009)...,s Energy Research Center (ERC) has been awarded a... develop methods of recovering and reusing the hea...O 2 ) compression process in a carbon capture syst...ate carbon capture and sequestration, or storage (...ouse gas, emitted into the atmosphere by coal-fire...
Breaking Biology News(10 mins):From toxic dust and algae to ill winds from Africa 2From toxic dust and algae to ill winds from Africa 3From toxic dust and algae to ill winds from Africa 4From toxic dust and algae to ill winds from Africa 5Discovery of new type of immune cells regulating inflammation in chronic diseases 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 3Enfina Healthcare Solutions Implements Business Process Outsourcing Services Software from DST Health Solutions 54066 1Enfina Healthcare Solutions Implements Business Process Outsourcing Services Software from DST Health Solutions 54066 2New Research Study May Lead to Personalized Approach to Breast Cancer Screenings 54063 1New Research Study May Lead to Personalized Approach to Breast Cancer Screenings 54063 2New Research Study May Lead to Personalized Approach to Breast Cancer Screenings 54063 3New Research Study May Lead to Personalized Approach to Breast Cancer Screenings 54063 4Baxa Corporation Launches Culture of Safety Facebook Page 54059 1Baxa Corporation Launches Culture of Safety Facebook Page 54059 2Baxa Corporation Launches Culture of Safety Facebook Page 54059 3
...What do the countries of Thailand, Uruguay and Gha...roducers of the emerging renewable fuel known as b...onsin-Madison Nelson Institute for Environmental S...m vegetable oils and animal fats has made it one o...ssil fuels. Seeking to understand which nations ar...
... Professor Laurette Dub, James McGill Chair in Con...convened an annual Health Challenge Think Tank bas...ealth issues in a comprehensive, effective way dem...s and areas of expertise. To that end, this years ...ientists, stakeholders and decision-makers, includ...
...as--Changes in the expression of genes may be the ...ay paint or glue, quickly develop a tolerance, bio...discovered. , The team, led by graduate student ...er as a model system to determine how the nervous ...olvent inhalants. , The team,s work appears in th...
Other Biology News:Researchers examine world's potential to produce biodiesel 2Researchers examine world's potential to produce biodiesel 3Changing the global dietary environment 2Tolerance to inhalants may be caused by changes in gene expression 2
...&D Systems adds two new Stem Cell Antibody Panels ...uman Embryonic Stem Cell Marker Antibody Panel (Ca...kaline phosphatase, Nanog, Oct-3/4, SSEA-1 and SSE... Panel Plus (Catalog # SC009) contains antibodies ...
Anti-Epstein-Barr Virus (EBV) (EBNA-1) Polyclonal Antibody, Biotin Conjugated from ViroStat Inc.
Rabbit Anti-ECE-1 Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Rat Anti-Mouse HAI-1 Ectodomain Monoclonal Antibody, Unconjugated, Clone 199732 from R&D Systems
Biology Products: